1987年获北京医科大学理学学士，1992年获美国伊利诺斯芝加哥大学医学教育管理硕士（MHPE）

1987年至今在药学院工作，曾先后任药事管理学教研室、临床药学教研室副主任、主任，北京医科大学药学院副院长，北京大学医学部副主任等。

1] Wushouer H, Zhang ZX, Wang JH, Ji P, Zhu QF, Aishan R, Shi LW#.Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: Based on a 3 year surveillance data, 2014-2016. J Infect Public Health. 2017 Oct 7. pii: S1876-0341(17)30256-3.


[2] Guo N, Zhang G, Zhu D#, Wang J, Shi L#.The effects of convenience and quality on the demand for vaccination: Results from a discrete choice experiment. Vaccine. 2017 May 15;35(21):2848-2854.


[3] Nie XY, Li JL, Zhang Y, Xu Y, Yang XL, Fu Y, Liang GK, Lu Y, Liu J#, Shi LW#. Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity. J Zhejiang Univ Sci B. 2017 Jan.;18(1):37-47.


[4] Guo N, Iversen T, Lu M, Wang J#, Shi L#. Does the new cooperative medical scheme reduce inequality in catastrophic health expenditure in rural China? BMC Health Serv Res. 2016 Nov 14;16(1):653.


[5] Xiao-Xiong Xin, Liang Zhao, Xiao-Dong Guan,Lu-Wen Shi#. Determinants and Equity Evaluation for Health Expenditure among Patients with Rare Diseases in China. Chinese Medical Journal. 2016, June 129(12):1387-1393.


[6] Xiaoxiong Xin, Xiaodong Guan, Luwen Shi#. Catastrophic expenditure and impoverishment of patients affected by 7 rare diseases in China. Orphanet Journal of Rare Diseases. 2016,June6; 11:74.


[7] Tiansheng Wang, Fei Wang, Xiaoxiong Xin, Roy A. Pleasants, Luwen Shi#. Methods for using microblogs for health communication with a pharmacist-based accout[J]. Patients Education and Counseling, 2016 Aug;99(8):1432-7.


[8] Wu M, Lu P, Shi L#, Li S. Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis. Oncotarget. 2015 Nov 10;6(35):38283-95.


[9] Tiansheng Wang, Amy Seybert, Chunyang Hu, Xiaoquan Wu, Ye Chen, Xiaodong Guan, Luwen Shi#. Development and Evaluation of the Application-Based Case Study Program. J Pharma Care Health Sys 2015, 2:3.


[10]Sun F, Chai S, Yu K, Quan X, Yang Z, Wu S, Zhang Y, Ji L, Wang J#, Shi L#. Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetes Technol Ther, 2015,1:35-42.


[11]SIRI Guleng, LIU Xiao-Ling, LI Tong-Mei,SHI Lu-Wen#..Rapid Determination of Bile Acids in Bile from Various Mammals by Ultra-fast Liquid Chromatography. Chinese J. Anal. Chem. 2015, 43(5):675-681.


[12]Si GL, Yao P, Shi L#. Rapid Determination of Bile Acids in Bile from Various Mammals by Reversed-Phase Ultra-Fast Liquid Chromatography. J Chromatogr Sci. 2015 Aug;53(7):1060-1065.


[13]Wang T, Benedict N, Olsen KM, Luan R, Zhu X, Zhou N, Tang H, Yan Y, Peng Y, Shi L#. Effect of critical care pharmacist's intervention on medication errors: A systematic review and meta-analysis of observational studies. J Crit Care. 2015 Jun 24. pii: S0883-9441(15)00360-3.


[14]Zhao Y, Han S, Shang J, Zhao X, Pu R, Shi L#. Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis[J]. J Asthma, 2015, 52(8), 846-857


[15]Wang T, Wang F, Shi L#. The use of microblog-based case studies in a pharmacotherapy introduction class in China[J]. BMC Med Educ. 2013 Sep 8;13:120.


[16]Guan X, Liang H, Xue Y, Shi L#. An analysis of China's national essential medicines policy[J]. J Public Health Policy, 2011,3:305-319.


[17]陈敬,史录文#.美国药品专利链接制度中专利登记规则研究[J].中国新药杂志,2017,26(13):1484-1487.


[18]官海静,韩晟,王雅楠,李成明,郑丽英,史录文#.肾炎康复片联合西医常规治疗糖尿病肾病的药物经济学研究[J].中国新药杂志,2017,26(20):2491-2496.


[19]满春霞,管晓东,邹武捷,郭志刚,马莉莉,刘伊,史录文#.我国各省药品集中招标采购政策分析和思考[J].中国卫生政策研究,2016,(07):53-59.


[20]管晓东,林其敏,信枭雄,张宇晴,朱冰玉,史录文#.药品可负担性评价方法研究[J].中国药房,2015(28):3892-3895.